These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11452706)

  • 1. The pharmacokinetics of irbesartan in hypertensive children and adolescents.
    Sakarcan A; Tenney F; Wilson JT; Stewart JJ; Adcock KG; Wells TG; Vachharajani NN; Hadjilambris OW; Slugg P; Ford NF; Marino MR
    J Clin Pharmacol; 2001 Jul; 41(7):742-9. PubMed ID: 11452706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual and joint association of alpha1A-adrenergic receptor Arg347Cys polymorphism and plasma irbesartan concentration with blood pressure therapeutic response in Chinese hypertensive subjects.
    Jiang S; Mao G; Zhang S; Hong X; Tang G; Li Z; Liu X; Zhang Y; Wang B; Xu X; Wang X
    Clin Pharmacol Ther; 2005 Sep; 78(3):239-48. PubMed ID: 16153395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of irbesartan in healthy subjects.
    Marino MR; Langenbacher K; Ford NF; Uderman HD
    J Clin Pharmacol; 1998 Mar; 38(3):246-55. PubMed ID: 9549663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of cigarette smoking with steady-state plasma concentration of irbesartan in male Chinese with hypertension.
    Zhang S; Liu P; Jiang S; Hong X; Xing H; Xu X
    Methods Find Exp Clin Pharmacol; 2005 Apr; 27(3):173-8. PubMed ID: 15834449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of effect of food on the oral bioavailability of irbesartan in healthy male volunteers.
    Vachharajani NN; Shyu WC; Mantha S; Park JS; Greene DS; Barbhaiya RH
    J Clin Pharmacol; 1998 May; 38(5):433-6. PubMed ID: 9602956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics and pharmacodynamics of irbesartan in heart failure.
    Kostis JB; Vachharajani NN; Hadjilambris OW; Kollia GD; Palmisano M; Marino MR
    J Clin Pharmacol; 2001 Sep; 41(9):935-42. PubMed ID: 11549097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug interactions with irbesartan.
    Marino MR; Vachharajani NN
    Clin Pharmacokinet; 2001; 40(8):605-14. PubMed ID: 11523726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2C9 3 and 13 alleles significantly affect the pharmacokinetics of irbesartan in healthy Korean subjects.
    Choi CI; Kim MJ; Chung EK; Lee HI; Jang CG; Bae JW; Lee SY
    Eur J Clin Pharmacol; 2012 Feb; 68(2):149-54. PubMed ID: 21842338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of irbesartan are not altered in special populations.
    Marino MR; Vachharajani NN
    J Cardiovasc Pharmacol; 2002 Jul; 40(1):112-22. PubMed ID: 12072584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irbesartan: a review of its use in hypertension and in the management of diabetic nephropathy.
    Croom KF; Curran MP; Goa KL; Perry CM
    Drugs; 2004; 64(9):999-1028. PubMed ID: 15101793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics of irbesartan in renal failure and maintenance hemodialysis.
    Sica DA; Marino MR; Hammett JL; Ferreira I; Gehr TW; Ford NF
    Clin Pharmacol Ther; 1997 Dec; 62(6):610-8. PubMed ID: 9433389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, tolerability, pharmacokinetics, and pharmacodynamics of fimasartan following single and repeated oral administration in the fasted and fed states in healthy subjects.
    Chi YH; Lee H; Paik SH; Lee JH; Yoo BW; Kim JH; Tan HK; Kim SL
    Am J Cardiovasc Drugs; 2011 Oct; 11(5):335-46. PubMed ID: 21910510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactive effect of angiotensin II type 1 receptor (AGT1R) polymorphisms and plasma irbesartan concentration on antihypertensive therapeutic responses to irbesartan.
    Jiang S; Hsu YH; Venners SA; Zhang Y; Xing H; Wang X; Xu X
    J Hypertens; 2011 May; 29(5):890-5. PubMed ID: 21346624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 24-hour blood pressure control by once-daily administration of irbesartan assessed by ambulatory blood pressure monitoring. Irbesartan Multicenter Investigators' Group.
    Fogari R; Ambrosoli S; Corradi L; Degli Esposti E; Mos L; Nami R; Nicrosini F; Pessina AC; Salvetti A; Vaccarella A; Zanchetti A; Martin A; Reeves RA
    J Hypertens; 1997 Dec; 15(12 Pt 1):1511-8. PubMed ID: 9431859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of irbesartan, an angiotensin II AT1-receptor antagonist, in mice, rats, rabbits, and macaques.
    Davi H; Tronquet C; Miscoria G; Perrier L; DuPont P; Caix J; Simiand J; Berger Y
    Drug Metab Dispos; 2000 Jan; 28(1):79-88. PubMed ID: 10611144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and bioequivalence study of irbesartan tablets after a single oral dose of 300 mg in healthy Thai volunteers.
    Wittayalertpanya S; Chariyavilaskul P; Prompila N; Sayankuldilok N; Eiamart W
    Int J Clin Pharmacol Ther; 2014 May; 52(5):431-6. PubMed ID: 24725445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irbesartan for hypertension.
    Med Lett Drugs Ther; 1998 Jan; 40(1019):18-9. PubMed ID: 9465857
    [No Abstract]   [Full Text] [Related]  

  • 18. The relationship between the plasma concentration of irbesartan and the antihypertensive response is disclosed by an angiotensin II type 1 receptor polymorphism: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs. Atenolol (SILVHIA) Trial.
    Kurland L; Hallberg P; Melhus H; Liljedahl U; Hashemi N; Syvänen AC; Lind L; Kahan T
    Am J Hypertens; 2008 Jul; 21(7):836-9. PubMed ID: 18464745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactive Effect of the KCNJ11 Ile337Val Polymorphism and Cigarette Smoking on the Antihypertensive Response to Irbesartan in Chinese Hypertensive Patients.
    Jiang S; Venners SA; Hsu YH; Weinstock J; Wang B; Xing H; Wang X; Xu X
    Am J Hypertens; 2016 May; 29(5):553-9. PubMed ID: 26304961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irbesartan/hydrochlorothiazide for the treatment of isolated systolic hypertension: a subgroup analysis of the INCLUSIVE trial.
    Chrysant SG; Neutel JM; Ferdinand KC;
    J Natl Med Assoc; 2009 Apr; 101(4):300-7. PubMed ID: 19397219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.